SEO URLwww.firestrike.ai/deals/catalyst-clinical-research-worldwide-clinical-trials-acquisition-2026-6
acquisitionAnnounced · Feb 16, 2026Contract Research Organization (CRO)Source · CredibleArticle · Factual
Worldwide Clinical Trials acquires Catalyst Clinical Research
David Najork · Founding Software Engineer
Announced · Updated · 1 min read
Deal value
—
Target
Catalyst Clinical Research
Wilmington, North Carolina
Acquirer
Worldwide Clinical Trials
Full Acquisition
Status
Completed
Worldwide Clinical Trials agreed to acquire Catalyst Clinical Research. Reported deal value: Undisclosed. Status: Completed. Sector: Contract Research Organization (CRO). Target headquarters context: Wilmington, North Carolina, United States.
This page summarizes publicly available information about the transaction as of 2026-02-16. Figures and status may change as filings and press coverage update.
Worldwide Clinical Trials , a global contract research organization , has completed its acquisition of Catalyst Clinical Research , LCC – a specialized oncology CRO and scalable functional service provider
Deal timeline
Announced
Feb 16, 2026 · aijourn.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in Contract Research Organization (CRO). Figures and status may change as sources update.
Sources: aijourn.com · Primary article · FireStrike proprietary index